Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Ethical Issues

Ethical Issues

Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:

Drug Administration and Therapy Phases: Overview

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...

Ethical Dilemmas II

Ethical Dilemmas II

Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:

Nursing Ethical Principles II

Nursing Ethical Principles II

Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Assessment and Appraisal of Drug Innovativeness in Italy: Ultimate Evidence on Key Drivers and Consistency.

Journal of market access & health policy·2026

Same author

More and earlier data from AIFA: do they impact on the regional policies? Results from an exploratory analysis.

Global & regional health technology assessment·2026

Same author

Global & regional health technology assessment·2026

Same author

Global & regional health technology assessment·2026

Same author

Horizon scanning and drug expenditure for rare diseases: three-year predictive model in Italy 2025-2027.

Health economics review·2025

Same author

Global & regional health technology assessment·2025

Search research articles

Related Experiment Video

Updated: Sep 30, 2025

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Published on: February 16, 2011

Facilitating [corrected] More Efficient Negotiations for Innovative Therapies: A Value-Based Negotiation Framework.

Amanda Whittal¹, Claudio Jommi², Gérard De Pouvourville³

¹Dolon Ltd., London, United Kingdom.

International Journal of Technology Assessment in Health Care

|March 11, 2022

Summary

This summary is machine-generated.

Managed entry agreements (MEAs) facilitate patient access to innovative therapies. A new value-based negotiation framework streamlines MEA discussions between manufacturers and payers, improving transparency and efficiency.

Keywords:

Innovative therapies Managed entry agreements Negotiation framework

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

Related Experiment Videos

Last Updated: Sep 30, 2025

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Published on: February 16, 2011

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

Area of Science:

Health economics and outcomes research
Pharmaceutical policy
Healthcare access and innovation

Background:

Innovative therapies like gene and cell treatments face access delays due to differing manufacturer and payer perspectives on value and uncertainty.
Managed entry agreements (MEAs) offer a pathway for reimbursement when conventional methods are insufficient.
Current MEA processes lack a structured approach for decision-making and implementation.

Purpose of the Study:

To propose a conceptual value-based negotiation framework to structure MEA discussions.
To facilitate systematic identification and prioritization of concerns for both manufacturers and payers.
To enable selection of MEA terms that address concerns with minimal implementation burden.

Main Methods:

Development of the framework through iterative scientific literature review.
Incorporation of expert input throughout the framework development process.

Main Results:

A structured framework designed to systematically identify and prioritize concerns.
Tools to support the selection of mutually acceptable MEA terms.
Focus on minimizing implementation burden for selected MEA terms.

Conclusions:

The proposed framework aims to support more structured and transparent negotiations between payers and manufacturers.
It seeks to balance the needs of both parties, leading to quicker MEA negotiations.
Ultimately, the framework intends to improve patient access to innovative treatments.